Working… Menu

Dose Finding Study to Evaluate Safety, Tolerability and Immunogenicity of an Inactiviated Adjuvanted Sars-Cov-2 Virus Vaccine Candidate Against Covid-19 in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04671017
Recruitment Status : Active, not recruiting
First Posted : December 17, 2020
Last Update Posted : March 9, 2021
National Institute for Health Research, United Kingdom
Information provided by (Responsible Party):
Valneva Austria GmbH

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : February 26, 2021
Estimated Study Completion Date : August 28, 2021